NPI: 1437538618 · ONTARIO, CA 91761 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/21/2015
Authorized official WEY, SAM controls 14+ related entities in our dataset. Read more
| Authorized Official | WEY, SAM (VP LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 05/21/2015 |
Other providers sharing the same authorized official: WEY, SAM
| Provider | City | State | Total Paid |
|---|---|---|---|
| SAPELO DIALYSIS LLC | SAN LEANDRO | CA | $9.71M |
| DVA HEALTHCARE RENAL CARE INC | CHINO | CA | $4.52M |
| DVA HEALTHCARE RENAL CARE INC | SAN FRANCISCO | CA | $1.82M |
| NUEVO DIALYSIS LLC | LAGUNA HILLS | CA | $1.57M |
| CAPES DIALYSIS LLC | SEARCY | AR | $1.51M |
| TOTAL RENAL CARE INC | SANTA ROSA | CA | $818K |
| RENAL TREATMENT CENTERS-SOUTHEAST, LP. | GRETNA | LA | $796K |
| TARGHEE DIALYSIS, LLC | CINCINNATI | OH | $514K |
| GREENWOOD DIALYSIS LLC | TULSA | OK | $74K |
| DVA RENAL HEALTHCARE INC | DURHAM | NC | $10K |
| RENAL CENTER OF MOOREFIELD LLC | MOOREFIELD | WV | $8K |
| BLISS DIALYSIS LLC | BROKEN ARROW | OK | $6K |
| VILLAGEHEALTH DM LLC | DENVER | CO | $0.00 |
| SAKDC - DAVITA DIALYSIS PARTNERS LP | FLORESVILLE | TX | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 800 | $123K |
| 2019 | 2,947 | $243K |
| 2020 | 1,605 | $216K |
| 2021 | 2,424 | $223K |
| 2022 | 2,915 | $193K |
| 2023 | 10,241 | $669K |
| 2024 | 12,047 | $961K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,667 | 1,503 | $2.61M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,001 | 606 | $15K |
| A4657 | Syringe, with or without needle, each | 1,292 | 365 | $877.01 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 480 | 302 | $188.47 |
| J1756 | Injection, iron sucrose, 1 mg | 2,359 | 575 | $165.75 |
| J1270 | Injection, doxercalciferol, 1 mcg | 935 | 120 | $40.89 |
| 83970 | 199 | 197 | $0.00 | |
| 83540 | 90 | 81 | $0.00 | |
| 85048 | 202 | 197 | $0.00 | |
| 85041 | 201 | 196 | $0.00 | |
| 82728 | 84 | 82 | $0.00 | |
| 0250 | 3,365 | 183 | $0.00 | |
| 83550 | 34 | 27 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 41 | 41 | $0.00 |
| 90674 | 16 | 12 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 13 | 13 | $0.00 |